PCOS and Hair Loss: Why It Happens and How to Protect Your Scalp
Losing hair to PCOS is not the same as losing hair from stress. The distinction matters a great deal for what happens next.
Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions affecting women of reproductive age, and hair thinning is among its most distressing symptoms. The loss is slow, positional, and rooted in androgen activity at the follicle level rather than a single triggering event. That means the usual reassurances, "it will grow back once your stress improves," often do not apply. This guide explains how PCOS drives hair loss, what pattern to expect, when to involve a doctor, and what role scalp care plays alongside medical treatment. It does not replace medical advice; it prepares you to have a more informed conversation with the specialists who can help.
What PCOS Does to Hair Follicles
PCOS is a hormonal condition characterized by elevated androgens (male-type hormones such as testosterone and DHEA-S), irregular ovulation, and often polycystic ovaries visible on ultrasound. The World Health Organization estimates that 10 to 13 percent of women of reproductive age have PCOS, a common hormonal condition in this group.
The connection between PCOS and hair loss runs through androgens. Androgens, including a form called DHT (dihydrotestosterone), are thought to play a central part. DHT acts on the dermal papilla, the cluster of cells at the base of the follicle, and shortens the hair growth cycle (International Journal of Trichology, 2020). The picture is not fully settled, though: only about one third of women with female pattern hair loss have elevated androgen levels, according to a 2023 review in Diagnostics, and genetics play a large part too.
What happens at the follicle level is a process called miniaturization. Androgen-sensitive follicles, which are most concentrated at the crown and along the part line, respond to DHT by progressively shrinking. Each growth cycle, the follicle produces a slightly thinner, shorter hair strand. Over months and years, what were once thick terminal hairs become fine vellus hairs that are barely visible. The follicle itself is not dead at this stage, but it is compromised.
Not every woman with PCOS experiences significant hair loss. The degree of follicle response depends on genetic androgen sensitivity, meaning two women with identical hormone levels can have very different hair outcomes. This is why "PCOS" alone does not predict how much hair you will lose, but it does identify the mechanism that is most likely responsible when loss does occur.
A 2025 systematic review and meta-analysis found that the pooled prevalence of female pattern hair loss in patients with PCOS was 22.7%, and the pooled prevalence of PCOS in patients with female pattern hair loss was 32.3%, suggesting a bidirectional relationship between the two conditions. Researchers believe DHT acts on the dermal papilla at the base of the follicle and shortens the hair growth cycle (International Journal of Trichology, 2020).
Recognizing the PCOS Hair Pattern
The pattern matters, because it tells you both what is happening and, crucially, what is not happening. PCOS-related hair loss is a form of female androgenetic alopecia. Its distribution is specific and gradual, which distinguishes it from other types of loss that may look similar at first.
What the PCOS pattern looks like
- Widening of the center part line is typically the earliest visible sign. Hair remains present but the part appears broader than it used to.
- Reduced volume at the crown, especially visible under overhead lighting or when the hair is pulled back.
- Scalp visibility through the hair without obvious bald patches. The loss is diffuse within its zone, not absent in a localized spot.
- Intact frontal hairline, which differentiates the female androgenetic pattern from male pattern baldness. The temples and front hairline are usually preserved.
- Gradual onset, developing over months or years rather than appearing suddenly.
How it differs from telogen effluvium
Telogen effluvium is a separate condition in which a large proportion of follicles shift simultaneously into the resting phase following a physical or emotional trigger, producing a wave of diffuse shedding. Common triggers include illness, surgery, rapid weight loss, childbirth, or severe stress. The loss is typically global across the scalp, not concentrated at the crown, and it often self-resolves once the trigger is removed.
PCOS loss is slower, positional, and does not self-resolve, because the androgen signal is ongoing rather than event-based. The distinction matters for treatment: managing a trigger-based effluvium is different from managing a hormonal driver that requires medical intervention.
The two can co-exist. Women with PCOS may experience a telogen effluvium episode on top of underlying androgenetic thinning, which can make the total volume loss feel sudden and alarming even when the pattern was developing for years.
Associated symptoms to connect the dots
Because PCOS affects the whole hormonal system, hair loss rarely comes alone. Other androgen-excess signals worth noting include irregular or absent periods, acne (especially on the jawline and chin), unwanted terminal hair growth on the face or body (hirsutism), and difficulty with weight management. The presence of these alongside scalp thinning strengthens the case for a PCOS evaluation.
If you are experiencing hair thinning but none of these other signals, PCOS is less likely to be the primary cause. Other diagnoses including thyroid dysfunction, iron-deficiency anemia, and nutritional deficiencies produce hair loss without the androgen-excess context.
When to See a Doctor and Which One
Hair loss from PCOS is a medical issue with a medical diagnosis pathway. Scalp care and lifestyle changes can support the environment during treatment, but they do not address the underlying hormonal driver. The sooner the evaluation happens, the sooner treatment can start.
Which specialist to start with
Endocrinologist or reproductive endocrinologist for PCOS diagnosis and hormonal management. This is the right starting point if you suspect PCOS but have not been formally diagnosed, or if you have a PCOS diagnosis but your hormonal profile has not been evaluated in the context of hair loss.
Dermatologist or trichologist for hair loss evaluation. A scalp examination, hair pull test, and sometimes a scalp biopsy can confirm the pattern and rule out other causes. A dermatologist can also prescribe topical and oral medications for hair loss specifically.
Many women with PCOS benefit from working with both simultaneously - one managing the hormonal root cause, one managing the hair and scalp presentation.
What to expect from bloodwork
A thorough PCOS evaluation for hair loss typically includes the following. Bring this list to your appointment as a starting reference, not as a self-diagnostic checklist:
| Test | What It Measures | Why It Matters for Hair |
|---|---|---|
| Total testosterone | Overall androgen burden | Primary marker; elevated in most PCOS cases |
| Free testosterone / Free androgen index | Bioavailable androgen not bound to SHBG | More sensitive than total testosterone alone |
| SHBG (sex hormone-binding globulin) | Protein that binds and inactivates testosterone | Low SHBG means more free testosterone reaching follicles |
| DHEA-S | Adrenal androgen precursor | Helps distinguish ovarian vs. adrenal androgen source |
| Fasting insulin and fasting glucose | Insulin resistance markers | Insulin resistance amplifies androgen production in PCOS |
| Thyroid panel (TSH, T3, T4) | Thyroid function | Thyroid dysfunction is a common independent cause of hair loss |
| Ferritin / iron studies | Iron storage levels | Iron deficiency is a separate, very common cause of shedding |
This table is for orientation only. Your doctor will determine which tests apply based on your history and presentation. Do not interpret bloodwork without medical guidance.
Red flags that warrant faster action
- Sudden, rapid hair loss over days or weeks (not gradual thinning)
- Patchy, clearly demarcated bald spots (may indicate alopecia areata, a different condition)
- Scalp pain, burning, tenderness, or visible lesions
- Hair loss accompanied by masculinizing features such as deepening voice or significant clitoral enlargement (rare, but warrants immediate evaluation to rule out a hormone-producing tumor)
Medical Treatments That Help Hair
Several evidence-supported medical treatments can slow PCOS-related hair loss and, in some cases, support partial regrowth. None of them works overnight. Most require six to twelve months of consistent use before a meaningful clinical assessment is possible, and they need to be maintained long-term to preserve gains.
All of the following are prescription or physician-guided treatments. This section provides orientation, not a protocol to self-prescribe.
Spironolactone
Spironolactone is an anti-androgen medication, which means it works against the effects of androgens. It is believed to do this in part by stopping DHT from binding to androgen receptors. It is particularly relevant for PCOS because it addresses the hormonal mechanism directly rather than working solely at the scalp level.
A 2023 systematic review and meta-analysis found an overall improvement rate of 56.6% in female pattern hair loss with spironolactone, rising to 65.8% when combined with topical minoxidil. A randomized, double-blind, placebo-controlled trial found clinically meaningful improvement in 38% of the spironolactone group versus 9% of the placebo group, with both groups receiving twice-daily topical minoxidil as background therapy. Doses in the studies ranged from 25 to 200 mg daily (Cureus, 2023), and the 2023 international PCOS guideline notes that 25 to 100 mg daily appears to carry a lower risk of side effects. Results generally require one year or more to reach their peak.
The 2023 meta-analysis of spironolactone for female pattern hair loss (Aleissa, Cureus, 2023) pooled five studies (413 patients, only one of them a randomized trial) and found an improvement rate of 65.8% when spironolactone was combined with minoxidil, compared with 43.2% for spironolactone alone. The most common side effects were scalp pruritus, menstrual irregularity, and mild increased facial hair in some participants. Spironolactone is contraindicated in pregnancy.
Source: Efficacy and Safety of Oral Spironolactone in Female Pattern Hair Loss - Cureus, 2023
Topical minoxidil
Minoxidil is the most-recommended treatment for female pattern hair loss according to the American Academy of Dermatology, and the FDA has approved 2% and 5% minoxidil products for women. Anti-androgen medications are a separate kind of treatment, so in PCOS minoxidil is often combined with one rather than used alone.
In a 48-week randomized, placebo-controlled trial of 381 women (Lucky et al., JAAD, 2004), 5% minoxidil beat placebo on all three main measures of hair growth, 2% minoxidil beat placebo on most of them, and women rated the 5% strength as more beneficial than the 2% strength. Low-dose oral minoxidil has also been compared with 5% topical minoxidil in a randomized trial in women (Ramos et al., JAAD, 2020) and may be preferred by patients who find topical application difficult to maintain.
Oral contraceptives with anti-androgenic progestins
Combined oral contraceptives containing drospirenone (an anti-androgenic progestin) reduce circulating androgens through two mechanisms: suppressing ovarian androgen production and increasing SHBG, which binds free testosterone. They are used in PCOS management broadly and can help slow androgenetic hair loss as part of that hormonal correction.
The 2023 international PCOS guideline recommends considering these pills for excess hair growth and irregular cycles rather than for hair loss, and notes that the evidence for them specifically in PCOS is relatively limited. They are not appropriate for women trying to conceive, so it is worth planning any change with your doctor.
Metformin
Metformin is an insulin-sensitizing medication prescribed for PCOS patients with insulin resistance. Its effect on hair loss is indirect: by improving insulin sensitivity, it can reduce the excess insulin that drives androgen overproduction in the ovaries. Some evidence suggests metformin can improve hirsutism in PCOS patients, and reduced androgen burden may slow scalp hair loss over time. However, it is not a primary hair loss treatment, and its hair benefit evidence is weaker than that of spironolactone or minoxidil. It is most useful in patients where insulin resistance is contributing meaningfully to their androgen excess.
"Clients with PCOS often arrive frustrated that scalp products aren't fixing it. And they shouldn't be surprised. The job of scalp care in PCOS is to not add insult to injury while the medical protocol does its work. Protection, not correction."
Tina Mui, Certified Trichologist
What Scalp Care Does and Does Not Do
Being precise here matters, because the scalp care category has a credibility problem: products promise things they cannot deliver, and the resulting disappointment damages trust in things that do have genuine value.
What scalp care does not do: reverse PCOS-driven follicle miniaturization, lower circulating androgens, or replace the medical treatment that addresses the root hormonal cause. No shampoo, serum, or scalp massage reverses androgenetic alopecia. Any product claiming otherwise is overstating the evidence.
What scalp care genuinely does: maintains the best possible environment for follicles to function within their current capacity, and removes obstacles that compound medically-driven loss.
Specific barriers that scalp care helps address:
- Scalp inflammation from product buildup, sebum accumulation, or harsh cleansers can leave the scalp irritated. Scalp irritation is also a possible side effect of minoxidil (AAD), so avoiding extra irritants can make it easier to keep up a daily treatment routine.
- Barrier disruption from strong cleansers can leave some scalps feeling dry or irritated. Choosing a gentle cleanser is an easy way to avoid adding irritation.
- Mechanical damage from tight styles, aggressive brushing, and high-tension manipulation causes additional shedding on top of pattern loss, compounding the visible impact.
- Psychological dimension should not be minimized. The act of a consistent, attentive scalp routine provides a sense of agency during a period when much of the hair loss feels outside of your control.
The framing that holds up clinically is this: scalp care creates optimal conditions for medical treatments to work, and it prevents additional avoidable loss. That is a meaningful contribution, even if it is not the heroic rescue narrative that some products sell.
Daily Routine for PCOS-Adjacent Scalp
This is not a treatment protocol. It is a set of habits that removes friction and creates the best scalp conditions possible while medical treatment does its work. Think of it as harm reduction with a positive bias.
Cleansing
Wash the scalp, not just the hair. Most shampoos are applied primarily to the lengths and then rinsed through the scalp as an afterthought. During a period of hormonal disruption, the scalp itself is the priority. Apply shampoo directly to a wet scalp and work with fingertip pads, not nails. A thorough scalp wash reduces sebum, buildup, and the low-grade inflammation that compounds pattern loss.
Choose a gentle, SLS/SLES-free formula if your scalp is sensitive, since strong cleansing agents can leave some scalps feeling dry and irritated.
Frequency is individual. Women with oilier scalps may need to wash daily or every other day. Women who find that frequent washing causes dryness should focus on technique and formula rather than frequency.
Manipulation and styling
- Avoid tight, high-tension styles on areas where thinning is already visible. Traction alopecia (hair loss from repeated tension) layers on top of PCOS-pattern loss and accelerates the visible result. Ponytails, tight buns, and braids are the most common culprits.
- Use a wide-tooth comb on wet hair rather than a brush. Minimizing breakage protects hair that is already finer than it used to be.
- A silk or satin pillowcase may reduce nighttime friction on fine, thinning hair. It is a simple, low-effort option, though it is not a treatment.
- Volumizing styling techniques can help manage appearance while treatment progresses. Blow-drying roots upward, using a round brush at the crown, and avoiding heavy products that flatten fine hair all help maintain visual density.
Nutrition and supplementation
Several nutritional deficiencies, including low iron, vitamin D and zinc, have been studied in relation to hair loss, and a 2019 review in Dermatology and Therapy describes micronutrient deficiency as a possible modifiable risk factor, although the link is clearer for some nutrients than others.
Test before supplementing. Iron supplementation can be harmful in excess, and blanket supplementing without a confirmed deficiency is not recommended. Ask your doctor to include ferritin, vitamin D, and zinc in your next panel. If you are deficient, correcting it is worthwhile for your overall health and may help with shedding, although the same review notes that larger trials are still needed to confirm that supplementing improves hair growth.
Biotin and collagen supplementation are popular but have limited clinical evidence for hair loss in women without confirmed biotin deficiency. Check with your doctor before taking them, especially before bloodwork, and they should not be the centerpiece of a PCOS hair strategy.
Scalp massage
Regular scalp massage is described as having a relaxing effect and increasing blood flow to the skin. Some small-scale research suggests consistent scalp massage over several months may support hair thickness, though evidence for reversal of androgenetic loss specifically is limited. It is a low-risk, high-comfort practice that can be a pleasant part of a routine.
For more on the mechanics of scalp manipulation techniques, see our guide on why hair loss happens and what the scalp environment can influence.
What the Research Says About Hope
The honest evidence picture is nuanced. It is neither as discouraging as PCOS hair loss sometimes feels nor as recoverable as some marketing suggests. Here is what the research actually supports:
Early intervention slows progression significantly
Without treatment, female pattern hair loss can progress from a widening part to overall thinning, and the American Academy of Dermatology notes that treatment works best when started at the first sign of hair loss.
Regrowth is possible on miniaturized but not dead follicles
Hair follicles that are miniaturized can respond to treatment and produce thicker, longer hairs. How much a follicle can recover varies from person to person, so a dermatologist is the best person to tell you what is realistic for you.
Combined approaches may outperform single interventions
In a 2023 meta-analysis, studies that paired spironolactone with minoxidil reported a higher improvement rate (65.8%) than spironolactone alone (43.2%). Managing insulin resistance, addressing nutritional deficiencies, using an anti-androgen medication, and applying topical minoxidil each work through a different mechanism, which is why they are often used together. A comprehensive approach takes longer to set up and maintain.
The PCOS management dividend
Effective PCOS management has benefits well beyond hair. Hormonal birth control can help regulate periods, and some forms also improve acne and excess hair growth (Cleveland Clinic). Lifestyle changes have also been linked to a lower free androgen index in a Cochrane review. Managing PCOS for its systemic health effects often produces hair benefits as a positive secondary outcome, which reframes the motivation usefully: you are managing your hormonal health, and hair improvement is part of that.
A 2020 retrospective study in the Journal of the American Academy of Dermatology on spironolactone for female pattern hair loss (Burns et al., JAAD, 2020) found better results after 12 months of use than after 6 months, reinforcing that patience and consistency are not optional elements of treatment. A 48-week randomized, placebo-controlled trial of topical minoxidil in 381 women found that 5% minoxidil was superior to placebo on all three main measures of hair growth (Lucky et al., JAAD, 2004).
Sources: Burns et al., JAAD, 2020 (PubMed) | Lucky et al., JAAD, 2004 (PubMed)
Frequently Asked Questions
Can PCOS hair loss be reversed?
Partial regrowth is possible, particularly when treatment starts early. Once follicles are miniaturized but not fully dormant, medical treatments like minoxidil and spironolactone can help restore some density. How much density returns varies from person to person. The goal is to slow progression and preserve existing follicles, not wait until loss is advanced.
Does spironolactone regrow hair?
Clinical evidence shows spironolactone can meaningfully slow PCOS-related hair loss and, in some cases, support partial regrowth. A 2023 systematic review and meta-analysis found an overall improvement rate of about 57% among women with female pattern hair loss. Results typically require six to twelve months of consistent use and are most pronounced when spironolactone is combined with topical minoxidil.
What blood tests diagnose PCOS-related hair loss?
Your doctor will typically order total testosterone, free testosterone or free androgen index, sex hormone-binding globulin (SHBG), and DHEA-S to evaluate androgen levels. A metabolic panel (fasting glucose, fasting insulin, HbA1c) helps identify insulin resistance, which is common in PCOS and amplifies androgen activity. A pelvic ultrasound looks at the ovaries and is one of the three features doctors consider when diagnosing PCOS, and thyroid function is part of the blood work for female pattern hair loss, according to DermNet NZ. These tests should be interpreted by an endocrinologist or OB/GYN, not self-diagnosed.
How is PCOS hair loss different from regular hair loss?
PCOS-related hair loss follows a female androgenetic pattern: gradual thinning at the crown and along the part line, with the frontal hairline typically preserved. This differs from telogen effluvium, which causes sudden diffuse shedding across the whole scalp after a physical or emotional trigger. PCOS loss is slower and positional. It also often comes alongside other androgen-excess symptoms like irregular periods, acne, or unwanted facial hair.
Does weight loss improve PCOS hair loss?
For women with PCOS, a Cochrane review of 15 randomized trials found that lifestyle changes such as diet and exercise were associated with a lower free androgen index, a blood marker of androgen levels, although the evidence was low quality. Weight loss is not a standalone treatment for hair loss, but it can meaningfully support the hormonal environment that medical treatments are trying to correct.
- "Bi-directional association between female pattern hair loss and polycystic ovary syndrome: A systematic review and meta-analysis." JAAD International. 2025. JAAD International 2025
- Deswal R, Narwal V, Dang A, Pundir CS. "The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review." J Hum Reprod Sci. 2020. PMC7879843
- Carmina E, et al. "Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee." J Clin Endocrinol Metab. 2019. JCEM 2019
- Burns LJ, De Souza B, Flynn E, Hagigeorges D, Senna MM. "Spironolactone for treatment of female pattern hair loss." J Am Acad Dermatol. 2020. PubMed 32259535
- Aleissa M. "The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis." Cureus. 2023. PMC10502763
- Lucky AW, Piacquadio DJ, Ditre CM, et al. "A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss." J Am Acad Dermatol. 2004. PubMed 15034503
- Rodrigues-Barata R, Moreno-Arrones OM, Saceda-Corralo D, et al. "Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women." Skin Appendage Disord. 2020. PMC7325226
- Christ JP, Cedars MI. "Current Guidelines for Diagnosing PCOS." Diagnostics (Basel). 2023. PMC10047373
- Mathur R, Levin O, Azziz R. "Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome." Ther Clin Risk Manag. 2008. PMC2504056